nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—ADRB2—polycystic ovary syndrome	0.8	1	CbGaD
Bisoprolol—Respiratory distress—Metformin—polycystic ovary syndrome	0.00292	0.0591	CcSEcCtD
Bisoprolol—Ear pain—Metformin—polycystic ovary syndrome	0.00158	0.0319	CcSEcCtD
Bisoprolol—Injury—Metformin—polycystic ovary syndrome	0.00147	0.0296	CcSEcCtD
Bisoprolol—Alprenolol—ADRB3—polycystic ovary syndrome	0.00139	0.127	CrCbGaD
Bisoprolol—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00138	0.0279	CcSEcCtD
Bisoprolol—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00123	0.0249	CcSEcCtD
Bisoprolol—Breast disorder—Metformin—polycystic ovary syndrome	0.00122	0.0246	CcSEcCtD
Bisoprolol—Cramp muscle—Metformin—polycystic ovary syndrome	0.00121	0.0245	CcSEcCtD
Bisoprolol—Bevantolol—ADRA1A—polycystic ovary syndrome	0.0012	0.109	CrCbGaD
Bisoprolol—Pindolol—ADRB3—polycystic ovary syndrome	0.0012	0.109	CrCbGaD
Bisoprolol—Sweating increased—Metformin—polycystic ovary syndrome	0.00114	0.0229	CcSEcCtD
Bisoprolol—Drowsiness—Metformin—polycystic ovary syndrome	0.00104	0.021	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.000983	0.0199	CcSEcCtD
Bisoprolol—Bradycardia—Metformin—polycystic ovary syndrome	0.00095	0.0192	CcSEcCtD
Bisoprolol—Rhinitis—Metformin—polycystic ovary syndrome	0.000935	0.0189	CcSEcCtD
Bisoprolol—Hepatitis—Metformin—polycystic ovary syndrome	0.000933	0.0189	CcSEcCtD
Bisoprolol—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000928	0.0188	CcSEcCtD
Bisoprolol—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000919	0.0186	CcSEcCtD
Bisoprolol—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.000917	0.0185	CcSEcCtD
Bisoprolol—Eye disorder—Metformin—polycystic ovary syndrome	0.000872	0.0176	CcSEcCtD
Bisoprolol—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000866	0.0175	CcSEcCtD
Bisoprolol—Flushing—Metformin—polycystic ovary syndrome	0.000866	0.0175	CcSEcCtD
Bisoprolol—Angiopathy—Metformin—polycystic ovary syndrome	0.000846	0.0171	CcSEcCtD
Bisoprolol—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000841	0.017	CcSEcCtD
Bisoprolol—Erythema—Metformin—polycystic ovary syndrome	0.000812	0.0164	CcSEcCtD
Bisoprolol—Dysgeusia—Metformin—polycystic ovary syndrome	0.000795	0.0161	CcSEcCtD
Bisoprolol—Muscle spasms—Metformin—polycystic ovary syndrome	0.000781	0.0158	CcSEcCtD
Bisoprolol—Tremor—Metformin—polycystic ovary syndrome	0.000761	0.0154	CcSEcCtD
Bisoprolol—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000754	0.0152	CcSEcCtD
Bisoprolol—Chlorphenesin—CYP19A1—polycystic ovary syndrome	0.000737	0.067	CrCbGaD
Bisoprolol—Malaise—Metformin—polycystic ovary syndrome	0.000732	0.0148	CcSEcCtD
Bisoprolol—Syncope—Metformin—polycystic ovary syndrome	0.000728	0.0147	CcSEcCtD
Bisoprolol—Esmolol—ADRB2—polycystic ovary syndrome	0.000725	0.0659	CrCbGaD
Bisoprolol—Palpitations—Metformin—polycystic ovary syndrome	0.000718	0.0145	CcSEcCtD
Bisoprolol—Bevantolol—ADRB2—polycystic ovary syndrome	0.000716	0.0651	CrCbGaD
Bisoprolol—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000714	0.0144	CcSEcCtD
Bisoprolol—Myalgia—Metformin—polycystic ovary syndrome	0.000691	0.014	CcSEcCtD
Bisoprolol—Chest pain—Metformin—polycystic ovary syndrome	0.000691	0.014	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000687	0.0139	CcSEcCtD
Bisoprolol—Discomfort—Metformin—polycystic ovary syndrome	0.000683	0.0138	CcSEcCtD
Bisoprolol—Oedema—Metformin—polycystic ovary syndrome	0.000663	0.0134	CcSEcCtD
Bisoprolol—Infection—Metformin—polycystic ovary syndrome	0.000658	0.0133	CcSEcCtD
Bisoprolol—Propranolol—ADRB3—polycystic ovary syndrome	0.000654	0.0594	CrCbGaD
Bisoprolol—Shock—Metformin—polycystic ovary syndrome	0.000652	0.0132	CcSEcCtD
Bisoprolol—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00065	0.0131	CcSEcCtD
Bisoprolol—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000649	0.0131	CcSEcCtD
Bisoprolol—Skin disorder—Metformin—polycystic ovary syndrome	0.000644	0.013	CcSEcCtD
Bisoprolol—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000641	0.0129	CcSEcCtD
Bisoprolol—Betaxolol—ADRB2—polycystic ovary syndrome	0.000638	0.058	CrCbGaD
Bisoprolol—Atenolol—ADRB2—polycystic ovary syndrome	0.000633	0.0575	CrCbGaD
Bisoprolol—Hypotension—Metformin—polycystic ovary syndrome	0.000619	0.0125	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000604	0.0122	CcSEcCtD
Bisoprolol—Paraesthesia—Metformin—polycystic ovary syndrome	0.000595	0.012	CcSEcCtD
Bisoprolol—Dyspnoea—Metformin—polycystic ovary syndrome	0.000591	0.0119	CcSEcCtD
Bisoprolol—Somnolence—Metformin—polycystic ovary syndrome	0.000589	0.0119	CcSEcCtD
Bisoprolol—Acebutolol—ADRB2—polycystic ovary syndrome	0.000584	0.053	CrCbGaD
Bisoprolol—Dyspepsia—Metformin—polycystic ovary syndrome	0.000583	0.0118	CcSEcCtD
Bisoprolol—Oxprenolol—ADRB2—polycystic ovary syndrome	0.00058	0.0527	CrCbGaD
Bisoprolol—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000572	0.0116	CcSEcCtD
Bisoprolol—Fatigue—Metformin—polycystic ovary syndrome	0.000571	0.0115	CcSEcCtD
Bisoprolol—Constipation—Metformin—polycystic ovary syndrome	0.000567	0.0115	CcSEcCtD
Bisoprolol—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000546	0.011	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000542	0.011	CcSEcCtD
Bisoprolol—Alprenolol—ADRB2—polycystic ovary syndrome	0.00053	0.0482	CrCbGaD
Bisoprolol—Urticaria—Metformin—polycystic ovary syndrome	0.000527	0.0106	CcSEcCtD
Bisoprolol—Abdominal pain—Metformin—polycystic ovary syndrome	0.000524	0.0106	CcSEcCtD
Bisoprolol—Metoprolol—ADRB2—polycystic ovary syndrome	0.000493	0.0448	CrCbGaD
Bisoprolol—Asthenia—Metformin—polycystic ovary syndrome	0.000476	0.00961	CcSEcCtD
Bisoprolol—Pruritus—Metformin—polycystic ovary syndrome	0.000469	0.00948	CcSEcCtD
Bisoprolol—Pindolol—ADRB2—polycystic ovary syndrome	0.000456	0.0414	CrCbGaD
Bisoprolol—Diarrhoea—Metformin—polycystic ovary syndrome	0.000454	0.00916	CcSEcCtD
Bisoprolol—Dizziness—Metformin—polycystic ovary syndrome	0.000438	0.00886	CcSEcCtD
Bisoprolol—Vomiting—Metformin—polycystic ovary syndrome	0.000421	0.00852	CcSEcCtD
Bisoprolol—Rash—Metformin—polycystic ovary syndrome	0.000418	0.00844	CcSEcCtD
Bisoprolol—Dermatitis—Metformin—polycystic ovary syndrome	0.000418	0.00844	CcSEcCtD
Bisoprolol—Headache—Metformin—polycystic ovary syndrome	0.000415	0.00839	CcSEcCtD
Bisoprolol—Nausea—Metformin—polycystic ovary syndrome	0.000394	0.00796	CcSEcCtD
Bisoprolol—Propranolol—ADRB2—polycystic ovary syndrome	0.000249	0.0226	CrCbGaD
Bisoprolol—Propranolol—CYP1A1—polycystic ovary syndrome	0.000213	0.0194	CrCbGaD
Bisoprolol—ADRB2—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000125	0.000895	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000124	0.000892	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000124	0.000889	CbGpPWpGaD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000123	0.000881	CbGpPWpGaD
Bisoprolol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000122	0.000876	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000122	0.000871	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000121	0.000869	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000121	0.000866	CbGpPWpGaD
Bisoprolol—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000121	0.000865	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000121	0.000864	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000118	0.000847	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000118	0.000846	CbGpPWpGaD
Bisoprolol—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000113	0.00081	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000112	0.000802	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000111	0.000792	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00011	0.000789	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00011	0.000786	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000109	0.000784	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000108	0.000775	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000108	0.000771	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000107	0.00077	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000107	0.000769	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000101	0.000721	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.0001	0.000718	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—FSHR—polycystic ovary syndrome	9.99e-05	0.000716	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	9.99e-05	0.000716	CbGpPWpGaD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	9.91e-05	0.00071	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	9.88e-05	0.000708	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	9.85e-05	0.000706	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	9.85e-05	0.000706	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—FSHR—polycystic ovary syndrome	9.78e-05	0.000701	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	9.69e-05	0.000694	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NPB—polycystic ovary syndrome	9.66e-05	0.000693	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—LHB—polycystic ovary syndrome	9.57e-05	0.000686	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	9.48e-05	0.000679	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NPB—polycystic ovary syndrome	9.45e-05	0.000677	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—LHB—polycystic ovary syndrome	9.36e-05	0.000671	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	9.36e-05	0.000671	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	9.26e-05	0.000663	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	9.15e-05	0.000656	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	9.14e-05	0.000655	CbGpPWpGaD
Bisoprolol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	9.11e-05	0.000653	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—SCT—polycystic ovary syndrome	8.97e-05	0.000643	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	8.94e-05	0.000641	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	8.88e-05	0.000636	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.8e-05	0.000631	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—SCT—polycystic ovary syndrome	8.78e-05	0.000629	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	8.75e-05	0.000627	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.74e-05	0.000626	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—LHB—polycystic ovary syndrome	8.69e-05	0.000623	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—ADRB3—polycystic ovary syndrome	8.61e-05	0.000617	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.58e-05	0.000615	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.56e-05	0.000613	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	8.55e-05	0.000613	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—LHB—polycystic ovary syndrome	8.5e-05	0.000609	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	8.5e-05	0.000609	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—GNAS—polycystic ovary syndrome	8.4e-05	0.000602	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	8.37e-05	0.0006	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GNRH1—polycystic ovary syndrome	8.31e-05	0.000596	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	8.27e-05	0.000592	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	8.25e-05	0.000591	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—SCT—polycystic ovary syndrome	8.15e-05	0.000584	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	8.14e-05	0.000583	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PTGER3—polycystic ovary syndrome	8.07e-05	0.000578	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LHCGR—polycystic ovary syndrome	8.07e-05	0.000578	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	8.05e-05	0.000577	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—SCT—polycystic ovary syndrome	7.97e-05	0.000571	CbGpPWpGaD
Bisoprolol—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	7.94e-05	0.000569	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.89e-05	0.000565	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.89e-05	0.000565	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.77e-05	0.000557	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.6e-05	0.000545	CbGpPWpGaD
Bisoprolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.59e-05	0.000544	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.54e-05	0.000541	CbGpPWpGaD
Bisoprolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	7.42e-05	0.000532	CbGpPWpGaD
Bisoprolol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	7.39e-05	0.00053	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PTAFR—polycystic ovary syndrome	7.38e-05	0.000529	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.32e-05	0.000525	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRA1D—polycystic ovary syndrome	7.16e-05	0.000513	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	7.12e-05	0.000511	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	7.08e-05	0.000508	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.97e-05	0.000499	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—INHBB—polycystic ovary syndrome	6.94e-05	0.000498	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—INHBB—polycystic ovary syndrome	6.79e-05	0.000487	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	6.53e-05	0.000468	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.48e-05	0.000465	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	6.48e-05	0.000464	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	6.48e-05	0.000464	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	6.44e-05	0.000462	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PDE3B—polycystic ovary syndrome	6.34e-05	0.000454	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.32e-05	0.000453	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—GHRL—polycystic ovary syndrome	6.18e-05	0.000443	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	6.02e-05	0.000432	CbGpPWpGaD
Bisoprolol—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	6e-05	0.00043	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FSHR—polycystic ovary syndrome	5.9e-05	0.000423	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR ligand binding—POMC—polycystic ovary syndrome	5.78e-05	0.000414	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FSHR—polycystic ovary syndrome	5.77e-05	0.000414	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.74e-05	0.000411	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR ligand binding—POMC—polycystic ovary syndrome	5.65e-05	0.000405	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.61e-05	0.000402	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.55e-05	0.000398	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5.43e-05	0.000389	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.4e-05	0.000387	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRA1A—polycystic ovary syndrome	5.28e-05	0.000379	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	5.26e-05	0.000377	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FST—polycystic ovary syndrome	5.26e-05	0.000377	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	5.23e-05	0.000375	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.2e-05	0.000372	CbGpPWpGaD
Bisoprolol—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	5.19e-05	0.000372	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FST—polycystic ovary syndrome	5.15e-05	0.000369	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LHB—polycystic ovary syndrome	5.14e-05	0.000368	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	5.12e-05	0.000367	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	5.12e-05	0.000367	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ADRB3—polycystic ovary syndrome	5.08e-05	0.000364	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LHB—polycystic ovary syndrome	5.02e-05	0.00036	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GNRH1—polycystic ovary syndrome	5.02e-05	0.00036	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.91e-05	0.000352	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.86e-05	0.000348	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.85e-05	0.000348	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SCT—polycystic ovary syndrome	4.81e-05	0.000345	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.76e-05	0.000341	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.75e-05	0.00034	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.75e-05	0.00034	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SCT—polycystic ovary syndrome	4.71e-05	0.000337	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	4.63e-05	0.000332	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.59e-05	0.000329	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—FGF18—polycystic ovary syndrome	4.51e-05	0.000323	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.49e-05	0.000322	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—RBP4—polycystic ovary syndrome	4.47e-05	0.000321	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—FGF18—polycystic ovary syndrome	4.41e-05	0.000316	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.41e-05	0.000316	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—RBP4—polycystic ovary syndrome	4.38e-05	0.000314	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—GNAS—polycystic ovary syndrome	4.31e-05	0.000309	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	4.29e-05	0.000308	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	4.23e-05	0.000304	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	4.23e-05	0.000304	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—YAP1—polycystic ovary syndrome	4.18e-05	0.000299	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GAB1—polycystic ovary syndrome	4.12e-05	0.000295	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—YAP1—polycystic ovary syndrome	4.09e-05	0.000293	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	4.07e-05	0.000292	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GAB1—polycystic ovary syndrome	4.03e-05	0.000289	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—INSR—polycystic ovary syndrome	3.94e-05	0.000282	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	3.94e-05	0.000282	CbGpPWpGaD
Bisoprolol—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	3.92e-05	0.000281	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	3.88e-05	0.000278	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—INSR—polycystic ovary syndrome	3.85e-05	0.000276	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.74e-05	0.000268	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.68e-05	0.000264	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.66e-05	0.000262	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PGR—polycystic ovary syndrome	3.65e-05	0.000261	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.6e-05	0.000258	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PGR—polycystic ovary syndrome	3.57e-05	0.000256	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	3.46e-05	0.000248	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PLAT—polycystic ovary syndrome	3.39e-05	0.000243	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GHRL—polycystic ovary syndrome	3.39e-05	0.000243	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	3.35e-05	0.00024	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	3.35e-05	0.00024	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PLAT—polycystic ovary syndrome	3.32e-05	0.000238	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GHRL—polycystic ovary syndrome	3.32e-05	0.000238	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	3.3e-05	0.000236	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.27e-05	0.000234	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ATF1—polycystic ovary syndrome	3.23e-05	0.000232	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—POMC—polycystic ovary syndrome	3.2e-05	0.000229	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—ATF1—polycystic ovary syndrome	3.16e-05	0.000227	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.15e-05	0.000226	CbGpPWpGaD
Bisoprolol—ADRB1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.14e-05	0.000225	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—TCF7L2—polycystic ovary syndrome	3.09e-05	0.000221	CbGpPWpGaD
Bisoprolol—ADRB2—GPCR downstream signaling—AKT2—polycystic ovary syndrome	3.07e-05	0.00022	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	3.01e-05	0.000216	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NGFR—polycystic ovary syndrome	2.98e-05	0.000214	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—POMC—polycystic ovary syndrome	2.97e-05	0.000213	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—PRL—polycystic ovary syndrome	2.96e-05	0.000212	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	2.94e-05	0.000211	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NGFR—polycystic ovary syndrome	2.92e-05	0.000209	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—POMC—polycystic ovary syndrome	2.9e-05	0.000208	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—PRL—polycystic ovary syndrome	2.89e-05	0.000207	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.85e-05	0.000204	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	2.85e-05	0.000204	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.81e-05	0.000201	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	2.81e-05	0.000201	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.79e-05	0.0002	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	2.66e-05	0.000191	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	2.62e-05	0.000188	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—GNAS—polycystic ovary syndrome	2.6e-05	0.000187	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—GNAS—polycystic ovary syndrome	2.55e-05	0.000182	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	2.54e-05	0.000182	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	2.54e-05	0.000182	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.48e-05	0.000178	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	2.45e-05	0.000175	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—NRG1—polycystic ovary syndrome	2.43e-05	0.000174	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.43e-05	0.000174	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—NRG1—polycystic ovary syndrome	2.38e-05	0.000171	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	2.35e-05	0.000168	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	2.32e-05	0.000166	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	2.26e-05	0.000162	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	2.19e-05	0.000157	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	2.16e-05	0.000155	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	2.16e-05	0.000155	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IRS2—polycystic ovary syndrome	2.08e-05	0.000149	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—LEP—polycystic ovary syndrome	2.04e-05	0.000146	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IRS2—polycystic ovary syndrome	2.04e-05	0.000146	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—LEP—polycystic ovary syndrome	2e-05	0.000143	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	1.97e-05	0.000141	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	1.92e-05	0.000138	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—TH—polycystic ovary syndrome	1.87e-05	0.000134	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	1.86e-05	0.000133	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IRS1—polycystic ovary syndrome	1.82e-05	0.00013	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	1.82e-05	0.00013	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IRS1—polycystic ovary syndrome	1.78e-05	0.000128	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—POMC—polycystic ovary syndrome	1.75e-05	0.000126	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—INS—polycystic ovary syndrome	1.74e-05	0.000125	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—POMC—polycystic ovary syndrome	1.71e-05	0.000123	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	1.71e-05	0.000123	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	1.71e-05	0.000122	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—INS—polycystic ovary syndrome	1.7e-05	0.000122	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IGF1—polycystic ovary syndrome	1.69e-05	0.000121	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—AKT2—polycystic ovary syndrome	1.68e-05	0.000121	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	1.66e-05	0.000119	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IGF1—polycystic ovary syndrome	1.65e-05	0.000118	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—AKT2—polycystic ovary syndrome	1.65e-05	0.000118	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.6e-05	0.000115	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	1.6e-05	0.000115	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.57e-05	0.000112	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	1.54e-05	0.00011	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	1.52e-05	0.000109	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	1.52e-05	0.000109	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	1.45e-05	0.000104	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	1.43e-05	0.000103	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	1.41e-05	0.000101	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	1.38e-05	9.87e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling by GPCR—IL6—polycystic ovary syndrome	1.29e-05	9.24e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	1.28e-05	9.2e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling by GPCR—IL6—polycystic ovary syndrome	1.26e-05	9.04e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—TH—polycystic ovary syndrome	1.22e-05	8.75e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	1.19e-05	8.51e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	1.12e-05	8e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.1e-05	7.89e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.08e-05	7.72e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.04e-05	7.46e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.03e-05	7.36e-05	CbGpPWpGaD
Bisoprolol—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.02e-05	7.32e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	9.97e-06	7.14e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	9.5e-06	6.81e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	9e-06	6.45e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	8.39e-06	6.01e-05	CbGpPWpGaD
Bisoprolol—ADRB1—Signaling Pathways—IL6—polycystic ovary syndrome	7.61e-06	5.46e-05	CbGpPWpGaD
Bisoprolol—ADRB2—Signaling Pathways—IL6—polycystic ovary syndrome	7.45e-06	5.34e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	6.81e-06	4.88e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	6.71e-06	4.81e-05	CbGpPWpGaD
Bisoprolol—CYP3A4—Metabolism—INS—polycystic ovary syndrome	6.67e-06	4.78e-05	CbGpPWpGaD
